Longevity & AgingDrug-Releasing Cataract Lens Lowers Eye Pressure in Patients With Glaucoma
A drug-releasing artificial lens could simplify treatment for adults who have both cataracts and glaucoma. In a randomized study reported at an ophthalmology meeting, lenses carrying bimatoprost lowered eye pressure about as much as a standard lens paired with timolol eye drops over 12 months. Vision with corrective lenses was preserved, almost no patients needed extra glaucoma medication, and reported safety profiles were similar. The device is designed to release medication for three years, potentially reducing dependence on daily drops after cataract surgery. However, the article does not provide the randomized trial's size or detailed safety results, and three-year drug delivery remains a design goal rather than a result established by this comparison. Patients should discuss options with an ophthalmologist and continue prescribed treatment.
